Science writers, communicators, media, training, and public relations
This week on radio, Tim Thwaites is talking about diabetes in pregnancy, X-ray body scanners, the language gene, those slippery neutrinos, and more…
Read More about Diabetes in pregnancy, X-ray body scanners, the language gene, and those slippery neutrinos
This week on radio, Tim Thwaites is talking about dolphin friends; guns around the house; laundry lint; mosquitoes in the rain; and more… Read More about Dolphin friends, guns around the house, laundry lint and mosquitoes in the rain
The work should lead to a better understanding of autoimmune conditions, such as diabetes and rheumatoid arthritis, she says, and may even provide new ways to target treatments.
The human body incorporates multiple fail-safe mechanisms to protect it against the “friendly fire” from its immune system known as autoimmune disease, Charis Teh and colleagues at the […]
This week on radio, Tim Thwaites is talking about elephant cooperation; diabetes and pregnancy; sleepless betting; detecting Down syndrome; and more Read More about Sleepless betting, diabetes in pregnancy, and elephant cooperation
This week on radio, Tim Thwaites is talking about Twitter dialects; dazzling pirates; smart contact lenses; new urban bird species; and more Read More about Twitter dialects, dazzling pirates, and new urban birds
A young Monash University chemist and her colleagues have successfully strengthened insulin’s chemical structure without affecting its activity. Their new insulin won’t require refrigeration.
They have just filed a series of patents with the support of their long term commercial partner ASX-listed Circadian Technologies who are now negotiating with pharma companies to start the long […]
Media release: Geelong, Friday 23 April 2010
Modern drugs can stabilise adult onset diabetes but with some serious side effects. A Geelong-based company, Verva Pharmaceuticals, has a new approach – a drug used for many years to treat eye disease. In animal testing, the drug restored sensitivity to insulin. But will it be effective and safe in people? Read More about Eye drug finds new life in Geelong diabetes trial
